{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,19]],"date-time":"2026-02-19T02:56:18Z","timestamp":1771469778943,"version":"3.50.1"},"reference-count":34,"publisher":"Spandidos Publications","issue":"4","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2017,3]]},"DOI":"10.3892\/mmr.2017.6233","type":"journal-article","created":{"date-parts":[[2017,2,22]],"date-time":"2017-02-22T09:19:24Z","timestamp":1487755164000},"page":"2223-2228","source":"Crossref","is-referenced-by-count":20,"title":["microRNA-125b reverses the multidrug resistance of nasopharyngeal carcinoma cells via targeting of Bcl-2"],"prefix":"10.3892","volume":"15","author":[{"given":"Tai-Ze","family":"Yuan","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Huan-Huan","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xiao-Ling","family":"Lin","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jin-Xiu","family":"Yu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Qiu-Xiang","family":"Yang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yin","family":"Liang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jin","family":"Deng","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Lai-Ji","family":"Huang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xiu-Ping","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"2249","published-online":{"date-parts":[[2017,2,22]]},"reference":[{"key":"key20180108015027_b1-mmr-15-04-2223","first-page":"381","article-title":"Nasopharyngeal carcinoma incidence and mortality in China in 2010","volume":"33","author":"Wei","year":"2014","journal-title":"Chin J Cancer"},{"key":"key20180108015027_b2-mmr-15-04-2223","doi-asserted-by":"crossref","first-page":"325","DOI":"10.5732\/cjc.012.10189","article-title":"Trends in the survival of patients with nasopharyngeal carcinoma between 1976 and 2005 in Sihui, China: A population-based study","volume":"32","author":"Liu","year":"2013","journal-title":"Chin J Cancer"},{"key":"key20180108015027_b3-mmr-15-04-2223","year":"2015","journal-title":"GLOBOCAN 2012: Estimated cancer incidence, mortality and prevalence worldwide in 2012"},{"key":"key20180108015027_b4-mmr-15-04-2223","doi-asserted-by":"crossref","first-page":"398","DOI":"10.1016\/j.radonc.2013.10.020","article-title":"Long-term outcomes of intensity-modulated radiotherapy for 868 patients with nasopharyngeal carcinoma: An analysis of survival and treatment toxicities","volume":"110","author":"Sun","year":"2014","journal-title":"Radiother Oncol"},{"key":"key20180108015027_b5-mmr-15-04-2223","doi-asserted-by":"crossref","first-page":"1874","DOI":"10.1002\/cncr.25754","article-title":"Local control, survival, and late toxicities of locally advanced nasopharyngeal carcinoma treated by simultaneous modulated accelerated radiotherapy combined with cisplatin concurrent chemotherapy: Long-term results of a phase 2 study","volume":"117","author":"Xiao","year":"2011","journal-title":"Cancer"},{"key":"key20180108015027_b6-mmr-15-04-2223","doi-asserted-by":"crossref","first-page":"237","DOI":"10.1186\/s40880-015-0025-7","article-title":"Elevated peripheral blood lymphocyte-to- monocyte ratio predicts a favorable prognosis in the patients with metastatic nasopharyngeal carcinoma","volume":"34","author":"Jiang","year":"2015","journal-title":"Chin J Cancer"},{"key":"key20180108015027_b7-mmr-15-04-2223","doi-asserted-by":"crossref","first-page":"505","DOI":"10.1016\/j.ctrv.2008.03.002","article-title":"Combined action and regulation of phase II enzymes and multidrug resistance proteins in multidrug resistance in cancer","volume":"34","author":"Meijerman","year":"2008","journal-title":"Cancer Treat Rev"},{"key":"key20180108015027_b8-mmr-15-04-2223","doi-asserted-by":"crossref","first-page":"3169","DOI":"10.7314\/APJCP.2014.15.7.3169","article-title":"Prognostic factors on overall survival of newly diagnosed metastatic nasopharyngeal carcinoma","volume":"15","author":"Li","year":"2014","journal-title":"Asian Pac J Cancer Prev"},{"key":"key20180108015027_b9-mmr-15-04-2223","doi-asserted-by":"crossref","first-page":"225","DOI":"10.1158\/0008-5472.CAN-10-1850","article-title":"MiR-26a inhibits cell growth and tumorigenesis of nasopharyngeal carcinoma through repression of EZH2","volume":"71","author":"Lu","year":"2011","journal-title":"Cancer Res"},{"key":"key20180108015027_b10-mmr-15-04-2223","doi-asserted-by":"crossref","first-page":"454","DOI":"10.1093\/carcin\/bgs346","article-title":"MicroRNA-144 promotes cell proliferation, migration and invasion in nasopharyngeal carcinoma through repression of PTEN","volume":"34","author":"Zhang","year":"2013","journal-title":"Carcinogenesis"},{"key":"key20180108015027_b11-mmr-15-04-2223","doi-asserted-by":"crossref","first-page":"415","DOI":"10.1093\/carcin\/bgs329","article-title":"miR-18a promotes malignant progression by impairing microRNA biogenesis in nasopharyngeal carcinoma","volume":"34","author":"Luo","year":"2013","journal-title":"Carcinogenesis"},{"key":"key20180108015027_b12-mmr-15-04-2223","doi-asserted-by":"crossref","first-page":"554","DOI":"10.1093\/carcin\/bgt354","article-title":"miR-9 targets CXCR4 and functions as a potential tumor suppressor in nasopharyngeal carcinoma","volume":"35","author":"Lu","year":"2014","journal-title":"Carcinogenesis"},{"key":"key20180108015027_b13-mmr-15-04-2223","doi-asserted-by":"crossref","first-page":"1562","DOI":"10.1016\/j.febslet.2014.02.039","article-title":"Down-regulation of miRNA-204 by LMP-1 enhances CDC42 activity and facilitates invasion of EBV-associated nasopharyngeal carcinoma cells","volume":"588","author":"Ma","year":"2014","journal-title":"FEBS Lett"},{"key":"key20180108015027_b14-mmr-15-04-2223","doi-asserted-by":"crossref","first-page":"546","DOI":"10.1590\/1414-431X20131662","article-title":"Identification of microRNAs and mRNAs associated with multidrug resistance of human laryngeal cancer hep-2 cells","volume":"46","author":"Yin","year":"2013","journal-title":"Braz J Med Biol Res"},{"key":"key20180108015027_b15-mmr-15-04-2223","doi-asserted-by":"crossref","first-page":"1118","DOI":"10.2174\/13894501113149990183","article-title":"Function of miRNA in controlling drug resistance of human cancers","volume":"14","author":"Hong","year":"2013","journal-title":"Curr Drug Targets"},{"key":"key20180108015027_b16-mmr-15-04-2223","doi-asserted-by":"crossref","first-page":"786","DOI":"10.1002\/hed.21540","article-title":"MicroRNA expression profiles of head and neck squamous cell carcinoma with docetaxel-induced multidrug resistance","volume":"33","author":"Dai","year":"2011","journal-title":"Head Neck"},{"key":"key20180108015027_b17-mmr-15-04-2223","doi-asserted-by":"crossref","first-page":"e102403","DOI":"10.1371\/journal.pone.0102403","article-title":"MicroRNAs MiR-218, MiR-125b and Let-7g predict prognosis in patients with oral cavity squamous cell carcinoma","volume":"9","author":"Peng","year":"2014","journal-title":"PLoS One"},{"key":"key20180108015027_b18-mmr-15-04-2223","doi-asserted-by":"crossref","first-page":"4334","DOI":"10.1074\/jbc.M112.419168","article-title":"miR-125b functions as a key mediator for snail-induced stem cell propagation and chemoresistance","volume":"288","author":"Liu","year":"2013","journal-title":"J Biol Chem"},{"key":"key20180108015027_b19-mmr-15-04-2223","doi-asserted-by":"crossref","first-page":"e76247","DOI":"10.1371\/journal.pone.0076247","article-title":"miR-125b acts as a tumor suppressor in breast tumorigenesis via its novel direct targets ENPEP CK2-\u03b1, CCNJ, and MEGF9","volume":"8","author":"Feliciano","year":"2013","journal-title":"PLoS One"},{"key":"key20180108015027_b20-mmr-15-04-2223","doi-asserted-by":"crossref","first-page":"21496","DOI":"10.1074\/jbc.M109.083337","article-title":"MicroRNA-125b confers the resistance of breast cancer cells to paclitaxel through suppression of pro-apoptotic Bcl-2 antagonist killer 1 (Bak1) expression","volume":"285","author":"Zhou","year":"2010","journal-title":"J Biol Chem"},{"key":"key20180108015027_b21-mmr-15-04-2223","doi-asserted-by":"crossref","first-page":"541","DOI":"10.1097\/00001622-199511000-00012","article-title":"Regulation of apoptosis by bcl-2 family proteins and its role in cancer and chemoresistance","volume":"7","author":"Reed","year":"1995","journal-title":"Curr Opin Oncol"},{"key":"key20180108015027_b22-mmr-15-04-2223","doi-asserted-by":"crossref","first-page":"893","DOI":"10.2174\/138945006777709520","article-title":"The functions and structure of ABC transporters: Implications for the design of new inhibitors of Pgp and MRP1 to control multidrug resistance (MDR)","volume":"7","author":"Teodori","year":"2006","journal-title":"Curr Drug Targets"},{"key":"key20180108015027_b23-mmr-15-04-2223","doi-asserted-by":"crossref","first-page":"1933","DOI":"10.1073\/pnas.0401851102","article-title":"Intercellular transfer of P-glycoprotein mediates acquired multidrug resistance in tumor cells","volume":"102","author":"Levchenko","year":"2005","journal-title":"Proc Natl Acad Sci USA"},{"key":"key20180108015027_b24-mmr-15-04-2223","doi-asserted-by":"crossref","first-page":"2","DOI":"10.1002\/ijc.24782","article-title":"Role of microRNA in anticancer drug resistance","volume":"126","author":"Zheng","year":"2010","journal-title":"Int J Cancer"},{"key":"key20180108015027_b25-mmr-15-04-2223","first-page":"1437","article-title":"MicroRNA miR-125b is a prognostic marker in human colorectal cancer","volume":"38","author":"Nishida","year":"2011","journal-title":"Int J Oncol"},{"key":"key20180108015027_b26-mmr-15-04-2223","doi-asserted-by":"crossref","first-page":"2045","DOI":"10.1007\/s00432-012-1285-0","article-title":"Circulating miR-125b is a novel biomarker for screening non-small-cell lung cancer and predicts poor prognosis","volume":"138","author":"Yuxia","year":"2012","journal-title":"J Cancer Res Clin Oncol"},{"key":"key20180108015027_b27-mmr-15-04-2223","doi-asserted-by":"crossref","first-page":"3426","DOI":"10.1002\/cncr.26587","article-title":"MicroRNA expression profiling is a potential diagnostic tool for thyroid cancer","volume":"118","author":"Vriens","year":"2012","journal-title":"Cancer"},{"key":"key20180108015027_b28-mmr-15-04-2223","doi-asserted-by":"crossref","first-page":"130","DOI":"10.1186\/1476-4598-12-130","article-title":"miR-125b targets erythropoietin and its receptor and their expression correlates with metastatic potential and ERBB2\/HER2 expression","volume":"12","author":"Ferracin","year":"2013","journal-title":"Mol Cancer"},{"key":"key20180108015027_b29-mmr-15-04-2223","doi-asserted-by":"crossref","first-page":"702","DOI":"10.1038\/onc.2013.13","article-title":"Loss of miR-125b-1 contributes to head and neck cancer development by dysregulating TACSTD2 and MAPK pathway","volume":"33","author":"Nakanishi","year":"2014","journal-title":"Oncogene"},{"key":"key20180108015027_b30-mmr-15-04-2223","doi-asserted-by":"crossref","first-page":"6293","DOI":"10.1007\/s13277-014-1821-4","article-title":"miR-125b inhibitor enhance the chemosensitivity of glioblastoma stem cells to temozolomide by targeting Bak1","volume":"35","author":"Chen","year":"2014","journal-title":"Tumor Biol"},{"key":"key20180108015027_b31-mmr-15-04-2223","doi-asserted-by":"crossref","first-page":"7185","DOI":"10.1007\/s13277-015-3438-7","article-title":"The role of miR-125b-mitochondria-caspase-3 pathway in doxorubicin resistance and therapy in human breast cancer","volume":"36","author":"Xie","year":"2015","journal-title":"Tumor Biol"},{"key":"key20180108015027_b32-mmr-15-04-2223","doi-asserted-by":"crossref","first-page":"2248","DOI":"10.1002\/jcb.24574","article-title":"miR-125b regulates side population in breast cancer and confers a chemoresistant phenotype","volume":"114","author":"Wang","year":"2013","journal-title":"J Cell Biochem"},{"key":"key20180108015027_b33-mmr-15-04-2223","doi-asserted-by":"crossref","first-page":"543","DOI":"10.1007\/s11596-011-0487-z","article-title":"miR-125b confers resistance of ovarian cancer cells to cisplatin by targeting pro-apoptotic Bcl-2 antagonist killer 1","volume":"31","author":"Kong","year":"2011","journal-title":"J Huazhong Univ Sci Technolog Med Sci"},{"key":"key20180108015027_b34-mmr-15-04-2223","doi-asserted-by":"crossref","first-page":"957","DOI":"10.1038\/bjc.2015.85","article-title":"Mitochondrial apoptosis: Killing cancer using the enemy within","volume":"112","author":"Lopez","year":"2015","journal-title":"Br J Cancer"}],"container-title":["Molecular Medicine Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/spandidos-publications.com\/10.3892\/mmr.2017.6233\/download","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2018,1,8]],"date-time":"2018-01-08T03:44:32Z","timestamp":1515383072000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.spandidos-publications.com\/10.3892\/mmr.2017.6233"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,2,22]]},"references-count":34,"journal-issue":{"issue":"4","published-online":{"date-parts":[[2017,2,22]]},"published-print":{"date-parts":[[2017,3]]}},"alternative-id":["10.3892\/mmr.2017.6233"],"URL":"https:\/\/doi.org\/10.3892\/mmr.2017.6233","relation":{},"ISSN":["1791-2997","1791-3004"],"issn-type":[{"value":"1791-2997","type":"print"},{"value":"1791-3004","type":"electronic"}],"subject":[],"published":{"date-parts":[[2017,2,22]]}}}